Serum Anti-myeloperoxidase Antineutrophil Cytoplasmic Antibodies (MPO-ANCA) in Patients with Graves'' Disease Receiving Anti-thyroid Medication

Antibodies (MPO-ANCA) in Patients with Graves' Disease Receiving Anti-thyroid Medication Key words: anti-myeloperoxidase antineutrophil cytoplasmic antibodies (MPO-ANCA), Graves' disease, propylthiouracil Graves' disease is a common autoimmune disorder and can usually be treated by antithyroid drugs, including methimazole (MMI) and propylthiouracil (PTU).These drugs are known to have several adverse effects such as eruption, liver dysfunction and agranulocytosis.Furthermore manystudies have reported the development of anti-myeloperoxidase antineutrophil cytoplasmic antibody (MPO-